45 CFR § 180 compliance
D · 65
This hospital published part of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
○Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
75,684
Insurances with rates
32
CPT / HCPCS codes
12,017
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| RX-272162 | REVAKINAGENE TARORETCEL-LWEY 200,000 TO 440,000 CELL INTRAVITREAL IMPL | $2,000,000 | $800,000 | — | — | 0 |
| RX-13092 | FENTANYL CITRATE (BULK) 100 % MISC POWD | $1,335,402 | $534,161 | — | — | 0 |
| PX-62033483 | Omidubicel (Omisirge) IV Susp Allo Hct | $1,228,968 | $491,587 | — | — | 0 |
| PX-62033483 | Omidubicel (Omisirge) IV Susp Allo Hct | $1,228,968 | $491,587 | — | — | 0 |
| RX-239487 | BEZLOTOXUMAB 25 MG/ML IV SOLN | $1,214,281 | $485,713 | — | — | 0 |
| RX-251624 | RANIBIZUMAB-INIT FILL NEEDLE 10 MG/0.1 ML INTRAVITREAL SOLN | $872,000 | $348,800 | — | — | 0 |
| RX-210519 | EVEROLIMUS (IMMUNOSUPPRESSIVE) 0.25 MG PO TABS | $613,888 | $245,555 | — | — | 0 |
| RX-3762 | HYDROMORPHONE (BULK) 100 % MISC POWD | $569,288 | $227,715 | — | — | 0 |
| RX-274087 | GEMCITABINE 225 MG INTRAVESICAL IMPL | $552,000 | $220,800 | — | — | 0 |
| PX-62031403 | Single Lung Acq Dnw | $509,089 | $203,636 | — | — | 0 |
| PX-62031404 | Double Lung Acq Dnw | $509,089 | $203,636 | — | — | 0 |
| RX-5184 | MORPHINE (BULK) 100 % MISC POWD | $502,228 | $200,891 | — | — | 0 |
| RX-207101 | TEMOZOLOMIDE 100 MG IV SOLR | $483,900 | $193,560 | — | — | 0 |
| RX-542355 | TEMOZOLOMIDE IV CHEMO INFUSION | $483,900 | $193,560 | — | — | 0 |
| RX-269197 | FARICIMAB-SVOA 6 MG/0.05 ML INTRAVITREAL SYRG | $473,371 | $189,349 | — | — | 0 |
| RX-224484 | METHYLNALTREXONE 8 MG/0.4 ML SC SYRG | $471,240 | $188,496 | — | — | 0 |
| RX-543782 | GLUCARPIDASE IV INJECTION | $471,240 | $188,496 | — | — | 0 |
| RX-267844 | NOGAPENDEKIN ALFA INBAKIC-PMLN 400 MCG/0.4 ML INTRAVESICAL SOLN | $431,748 | $172,699 | — | — | 0 |
| RX-244648 | ONABOTULINUMTOXINA (COSMETIC) 100 UNIT IM SOLR | $407,105 | $162,842 | — | — | 0 |
| RX-213347 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) IV SOLN | $402,682 | $161,073 | — | — | 0 |
| PX-62031439 | Liver Acq Cad Adult Recip Dnw | $398,467 | $159,387 | — | — | 0 |
| PX-62031397 | Heart Acq Dnw | $374,889 | $149,956 | — | — | 0 |
| SUP-1016240 | HEART TOTAL ARTIFICAL | $374,100 | $149,640 | — | — | 0 |
| SUP-1016240 | HEART TOTAL ARTIFICAL | $374,100 | $149,640 | — | — | 0 |
| PX-62031410 | Kidney Acq Cad Adult Recip Dnw | $351,391 | $140,556 | — | — | 0 |
| RX-249630 | LONCASTUXIMAB TESIRINE-LPYL 10 MG IV SOLR | $350,099 | $140,040 | — | — | 0 |
| RX-212506 | PEGLOTICASE 8 MG/ML IV SOLN | $346,492 | $138,597 | — | — | 0 |
| RX-209545 | USTEKINUMAB 90 MG/ML SC SYRG | $333,638 | $133,455 | — | — | 0 |
| RX-244676 | TAGRAXOFUSP-ERZS 1,000 MCG/ML IV SOLN | $332,319 | $132,927 | — | — | 0 |
| RX-233603 | N.MENINGITIDIS B,LIPID FHBP RC 120 MCG/0.5 ML IM SYRG | $324,212 | $129,685 | — | — | 0 |
| SUP-1028092 | VAD HEARTMATE III-COMMERCIAL | $323,757 | $129,503 | — | — | 0 |
| SUP-1028092 | VAD HEARTMATE III-COMMERCIAL | $323,757 | $129,503 | — | — | 0 |
| RX-246816 | MITOMYCIN 40 MG X 2 INPY KIT | $306,867 | $122,747 | — | — | 0 |
| RX-255700 | TRAVOPROST 75 MCG INTRACAMERAL IMPL | $302,560 | $121,024 | — | — | 0 |
| PX-62032187 | Pancreas Acq Dnw | $295,617 | $118,247 | — | — | 0 |
| RX-541938 | DAUNORUBICIN-CYTARABINE LIPOSOMAL IV SOLR | $294,195 | $117,678 | — | — | 0 |
| RX-248206 | RAVULIZUMAB-CWVZ 100 MG/ML IV SOLN | $267,592 | $107,037 | — | — | 0 |
| PX-62031440 | Liver Acq Lrd Adult Rec | $261,671 | $104,668 | — | — | 0 |
| RX-254467 | BEREMAGENE GEPERPAVEC-SVDT 5 X 10EXP9 PFU/2.5 ML TP GEL | $260,000 | $104,000 | — | — | 0 |
| SUP-1012366 | LVAD HEARTMATE II | $258,000 | $103,200 | — | — | 0 |
| SUP-1012366 | LVAD HEARTMATE II | $258,000 | $103,200 | — | — | 0 |
| PX-62033729 | Heart Transportation | $253,085 | $101,234 | — | — | 0 |
| RX-239777 | NUSINERSEN (PF) 12 MG/5 ML IT SOLN | $244,394 | $97,758 | — | — | 0 |
| RX-253645 | FVIII REC,FC-VWF-XTEN,BDD-EHTL 4000 (+/-) UNIT IV SOLR | $238,492 | $95,397 | — | — | 0 |
| RX-245343 | POLATUZUMAB VEDOTIN-PIIQ 140 MG IV SOLR | $237,921 | $95,168 | — | — | 0 |
| RX-239861 | OCRELIZUMAB 30 MG/ML IV SOLN | $236,686 | $94,674 | — | — | 0 |
| RX-251074 | TEBENTAFUSP-TEBN 100 MCG/0.5 ML IV SOLN | $234,459 | $93,784 | — | — | 0 |
| SUP-1026425 | KIT IMPLANT PUMP HVAD | $226,950 | $90,780 | — | — | 0 |
| RX-15595 | BUPIVACAINE (BULK) 100 % MISC POWD | $211,242 | $84,497 | — | — | 0 |
| PX-62033726 | Heart Preservation Organ Sys | $209,560 | $83,824 | — | — | 0 |
Showing top 50 of 75,684 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.